Bill Reiland is a Managing Director and Chief Investment Officer of North Haven Expansion Credit and a Managing Director of Morgan Stanley based in New York. Over the course of his 35 years of experience, Mr. Reiland has invested, structured, and marketed over 100 credit and equity transactions representing over $10Bn. Mr. Reiland initially joined Morgan Stanley in 1993 and became Head of Morgan Stanley’s Global High Yield Debt Research department in 2001. Mr. Reiland was ranked as the top health care high-yield research analyst by Institutional Investor in 2000, 2001 and 2002. In 2006, Mr. Reiland joined MSPI where he led and executed private investments on behalf of Morgan Stanley. Mr. Reiland led investments in several of MSPI’s most successful investments, including JHP Pharmaceuticals and Grifols SA. In 2008, Mr. Reiland left Morgan Stanley and joined Leerink Swann, where he was responsible for originating, structuring and marketing debt securities. In 2013, Mr. Reiland became a partner at Oberland Capital Management, a structured fixed income and equity royalty fund. Mr. Reiland rejoined Morgan Stanley in 2014 to lead the North Haven Expansion Credit effort. Mr. Reiland’s experience also includes time at Bain & Co., Stanford Hospital, Cowen and Co., and Stifel Nicholas. Mr. Reiland graduated with a B.A. in Economics from Yale University and an MBA, with distinction, from the Tuck School of Graduate Business Administration, where he was a Tuck Scholar.
Bill is a member of the Morgan Stanley Expansion Capital

Potrebbe non includere tutti i membri del Team.

Il contenuto della presente pagina ha esclusivamente scopo informativo. È destinato a emittenti terzi e a coloro che cercano informazioni relative a strategie di investimento alternative. Le informazioni ivi contenute non rappresentano e non sono da intendersi come un’offerta di servizi di consulenza né come un’offerta di vendita o una sollecitazione all’acquisto di titoli in una giurisdizione nella quale tale offerta, sollecitazione, acquisto o vendita siano proibiti in base alle leggi in materia di titoli, assicurazione o alle altre leggi di tale giurisdizione.

Tutti gli investimenti comportano rischi, tra cui la perdita del capitale. Gli investimenti alternativi sono speculativi e comportano un rischio elevato. Questi investimenti sono adatti agli investitori che comprendono tale genere di rischi e sono disposti ad accettarli. Le performance possono essere volatili e gli investitori possono perdere la totalità o una quota consistente del capitale investito.

Fare riferimento alla pagina dei dettagli della strategia per informazioni importanti sulla strategia e ulteriori considerazioni sui rischi.


La presente comunicazione ha carattere promozionale.

It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.

Privacy & Cookies    •    Istruzioni per l'uso

©  Morgan Stanley. All rights reserved.